Antithrombin III NF Baxter 50 IU/ml powder aNd solvent for solution for injection/infusion Bulgária - bolgár - Изпълнителна агенция по лекарствата

antithrombin iii nf baxter 50 iu/ml powder and solvent for solution for injection/infusion

Бакстер България ЕООД - Антитромбин - 50 iu/ml powder and solvent for solution for injection/infusion

Ringer Baxter  solution for infusion Bulgária - bolgár - Изпълнителна агенция по лекарствата

ringer baxter  solution for infusion

Бакстер България ЕООД - Електролити - solution for infusion

Sorafenib Accord Európai Unió - bolgár - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Антинеопластични средства - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Glucose 5% + Sodium chloride 0,9% Baxter solution for infusion Bulgária - bolgár - Изпълнителна агенция по лекарствата

glucose 5% + sodium chloride 0,9% baxter solution for infusion

Бакстер България ЕООД - Натриев Хлорид, Глюкоза - solution for infusion